Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rhyz is the strategic investment and brand accelerator arm of Nu Skin Enterprises, focusing on consumer, technology, and manufacturing in the beauty, wellness, and lifestyle sectors. While it is not itself a life science, biotech, pharma, or healthcare company, it owns and invests in companies operating in those adjacent fields—e.g., BeautyBio (skincare and beauty devices) and Rhyz Analytical Labs (testing for beauty and wellness products). Rhyz does not have a clinical pipeline, therapeutic modalities, clinical targets, or indications. Its subsidiaries and investments focus on product innovation, manufacturing technology, and consumer brand expansion.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rhyz.